De novo generation of haematopoietic stem and progenitor cells (HSPCs) would enable autologous treatment of blood disorders but this goal has met many obstacles 1 . Specifically, derivation of engraftable haematopoietic stem cells (HSCs) from pluripotent stem cells has not yet been achieved [2][3][4] . To circumvent transition through a destabilizing pluripotency state, attempts have been made to reprogram non-haematopoietic cell types into HSCs, but these efforts have produced haematopoietic progenitor-like cells with poor engraftment potential [5][6][7][8][9][10] . The inability to generate HSCs could be explained by the inadequate microenvironmental cues for self-renewal of reprogrammed HSCs [11][12][13][14][15][16][17][18][19] . Mouse lymphoid cells have previously been reprogrammed into putative HSC-like cells through expression of eight transcription factors and using a recipient in vivo niche to support conversion 20 . Constitutive expression of transcription factors FOSB, GFI1, RUNX1, and SPI1 (FGRS) and co-culturing with an inductive vascular niche converted human adult endothelial cells into transplantable multipotent haematopoietic progenitors (rEC-MPPs) 9 . However, neither study yielded cells supporting adaptive immunity. HSC-like cells engineered from pre-B lymphoid progenitors were incapable of immune adaptation because they had already undergone Ig heavy chain recombination at the V(D)J locus. Similarly, CD34
De novo generation of haematopoietic stem and progenitor cells (HSPCs) would enable autologous treatment of blood disorders but this goal has met many obstacles 1 . Specifically, derivation of engraftable haematopoietic stem cells (HSCs) from pluripotent stem cells has not yet been achieved [2] [3] [4] . To circumvent transition through a destabilizing pluripotency state, attempts have been made to reprogram non-haematopoietic cell types into HSCs, but these efforts have produced haematopoietic progenitor-like cells with poor engraftment potential [5] [6] [7] [8] [9] [10] . The inability to generate HSCs could be explained by the inadequate microenvironmental cues for self-renewal of reprogrammed HSCs [11] [12] [13] [14] [15] [16] [17] [18] [19] . Mouse lymphoid cells have previously been reprogrammed into putative HSC-like cells through expression of eight transcription factors and using a recipient in vivo niche to support conversion 20 . Constitutive expression of transcription factors FOSB, GFI1, RUNX1, and SPI1 (FGRS) and co-culturing with an inductive vascular niche converted human adult endothelial cells into transplantable multipotent haematopoietic progenitors (rEC-MPPs) 9 . However, neither study yielded cells supporting adaptive immunity. HSC-like cells engineered from pre-B lymphoid progenitors were incapable of immune adaptation because they had already undergone Ig heavy chain recombination at the V(D)J locus. Similarly, CD34
+ progenitors from rEC-MPPs poorly differentiated into mature T cells 9 .
Endothelial to haemogenic endothelial cell and HSC transition (EHT) 21, 22 is mediated by signals from niche cells [23] [24] [25] within the aorta-gonad-mesonephros region 26 during a narrow developmental window. We therefore used in vitro modelling to determine the pathways that drive this ontological process 27 , without the need to transition through a unstable pluripotent state. To this end, we devised a tractable stepwise approach whereby conditional expression of FGRS in adult mouse endothelial cells co-cultured with an inductive vascular niche reprograms adult endothelial cells into engraftable HSCs (rEC-HSCs) that possess all attributes of bona fide HSCs. rEC-HSCs are capable of clonal self-renewal and serial multi-potent reconstitution of all haematopoietic lineages, including immunocompetent lymphoid cells that elicit antigen-specific adaptive immune responses.
Conditional FGRS in mECs generates HSPCs
Adult mouse vascular endothelial cells (mECs) were purified by flow cytometry to eliminate contaminating lymphatic endothelial cells and haematopoietic cells (Fig. 1a) . Freshly isolated mECs (from CD45.2 mice) transplanted with radio-protective bone marrow cells did not contribute to recipient (CD45.1 + ) haematopoiesis, showing that mEC preparations were free of contaminating host-derived HSPCs. Moreover, before conversion, mECs were expanded using culture conditions that do not permit HSPC propagation (Extended Data Fig. 1a, b) . Thus, mEC preparations were free of contaminating host-derived HSPCs capable of contributing to haematopoiesis in recipients.
To initiate conversion, mECs were transduced with doxycycline (dox)-inducible FGRS (FGRS-ECs) lentiviral vectors and co-cultured article reSearcH with vascular niche endothelial cells (VN-ECs) 11, 13, 19, 28, 29 (Fig. 1a) . VN-ECs cells were generated by enforced expression of the adenoviral E4ORF1 gene in human umbilical vein endothelial cells (HUVEC-E4ORF1). E4ORF1 mimics physiological activation of phosphorylated Akt in endothelial cells, enhancing their survival, while sustaining their pro-haematopoietic instructive angiocrine functions 11, 13, 19, 28, 29 . During conversion, FGRS-ECs transitioned through three sequential phases (Fig. 1a) : (1) 'induction-phase' (day 0-8) is initiated by dox-upregulation of conditional FGRS in VE-cadherin (VEcad) + RUNX1 − CD45 − lung mECs isolated from adult mice and co-culture with VN-ECs (Extended Data Fig. 1c) Fig. 1d-f ) and autonomous colony-forming cell (CFC) activity, independent of exogenous FGRS transgene expression (Fig. 1e) . Similar to human rEC-MPPs 9 , the reprogrammed mECs to HSPCs (rEC-HSPCs) are endowed with multi-lineage progenitor properties, yielding CFC-GEMM (granulocyte, erythrocyte, monocyte, megakaryocyte), CFC-GM (granulocyte, monocyte), and BFU-E (burst-forming unit erythroid) colonies (Fig. 1e) . (3) In the 'expansion phase' (day 20-28), the total number of short-term re-populating/ radio-protective cells and lin − c-Kit
− (hCD31 − )) cells increased (Fig. 1d) . Most rEC-LKS cells expand attached to VN-ECs, suggesting paracrine and juxtacrine angiocrine factors supplied by VN-ECs maintain and expand LKS cells (Extended Data Fig. 1g ). Angiocrine signals provided by VN-ECs are missing from bone-marrow-derived fibroblastic OP9-DLL1 cells, as co-culture of FGRS-ECs with OP9-DLL1 cells did not convert endothelial cells into CD45 + rEC-HSPCs (Fig. 1c, Extended Data Fig.  1h, i) . Furthermore, FGRS-transduction of OP9-DLL1 cells did not yield haematopoietic cells, indicating that endothelial cells have an innate plasticity, unlike fibroblastic cell types.
rEC-HSPCs engraft primary and secondary recipients
rEC-HSPCs were transplanted into congenic recipients to assess their function. Before transplantation at day 28, rEC-HSPCs had completed haematopoietic commitment, thus we discontinued dox treatment, turning-off FGRS expression (FGRS-off). To assess long-term engraftment, day 28 CD45.2 + lung-derived rEC-HSPCs (FGRS-off) (8.0 × 10 5 cells) were transplanted into lethally irradiated (950 cGy) congenic CD45.1 + recipients (Fig. 2a) . As controls, adult lung FGRS-ECs (8.0 × 10 5 )-in which FGRS was never turned on (no-dox)-were transplanted or PBS was injected (Fig. 2a) . Only CD45.2 + rEC-HSPCs could radio-protect and engraft lethally irradiated recipients (Extended Data Fig. 2a) . In contrast, no-dox lung FGRS-ECs failed to reconstitute haematopoiesis and did not radio-protect the recipient upon transplantation. Hence, purified adult mECs are not contaminated by donor-derived HSPCs and their conversion to engraftable haematopoietic cells requires transient FGRS expression.
CD45.2 + rEC-HSPC-derived myeloid and lymphoid cells were present in peripheral blood 4-20 weeks after transplantation (Fig. 2b,  Extended Data Fig. 2b, c) . The blood, bone marrow and spleens of recipients transplanted with rEC-HSPCs were replete with donorderived B cells and circulating naive, effector, memory, and γ δ T cells in + cells in the vicinity of VN-ECs (HUVEC-E4ORF1, stained with anti-human CD31 (hCD31)). Representative pictures (10×, scale bar, 100 µm). c, Left, FGRS-ECs grown on VN-ECs, OP9-DLL11, or in feeder-free conditions. Right, FGRS-transduced OP9 cells were grown on VN-ECs, OP9-DLL11 (transduced with E4ORF1), or feeder-free. Data represent mean ± s.e.m. (n = 5 conversion experiments run in technical triplicates for each condition); two-tailed unpaired t-test was used to compare to day 0 at each time point. **P < 0.01. d, Quantification of CD45 + LKS cells during conversion (left) and absolute cell number (right). VN-ECs were excluded by gating on human CD31 negative (hCD31 − ) population. Data represent mean ± s.e.m. (n = 5 conversion experiments run in technical triplicates for each condition); two-tailed unpaired t-test was used to compare to day 10 at each time point. e, rEC-LKS (LKS) or mECs (EC) were sorted at the indicated time points during conversion, and seeded in methylcellulose (no dox); colonies were analyzed 7 days later. Graphs show the quantification of the number of colonies per 2,500 cells plated (n = 5 conversion experiments run in technical triplicates for each condition).
article reSearcH numbers and physiologic ratios similar to mice engrafted with normal whole bone marrow (WBM) (Extended Data Fig. 3a-e) . Analysis of bone marrow cells revealed a normal frequency of donor-derived phenotypically marked HSCs (CD45.2
LKS; LKS-SLAM cells) in mice engrafted with rEC-HSPCs or normal WBM (6.6% ± 0.4 versus 8.0% ± 0.6), respectively (Fig. 2d, Extended Data Fig. 2d ). Thus, rEC-HSPC yielded LKS-SLAM cells that were as capable as WBM of long-term multi-lineage engraftment.
We examined the self-renewal potential of CD45.2 + rEC-HSPCs by transplanting unfractionated bone marrow from primary transplant recipients into lethally irradiated secondary recipients (Fig. 2a) . We detected CD45.2 + myeloid and lymphoid cells in the peripheral blood of secondary recipients from 4 to 20 weeks after transplantation (Fig. 2c, Extended Data Fig. 2e ). The number of LKS-SLAM cells was comparable in secondary recipients of rEC-HSPCs and WBM (6.6% ± 0.3 versus 7.1% ± 0.6) (Fig. 2e) . Following sublethal (500 cGy) irradiation, secondary recipients of both rEC-HSPCs and WBM rapidly reconstituted multi-lineage haematopoiesis (Extended Data Fig. 2f-h) . Thus, engrafted rEC-HSPCs tolerate myelosuppressive stress and reconstitute serial long-term primary and secondary LKS-SLAM and multi-lineage haematopoiesis, suggesting robust in vivo self-renewal comparable to native WBM HSCs. Therefore, subsets of rEC-HSPCs are composed of reprogrammed engraftable rEC-HSCs.
rEC-HSC clonal and limiting-dilution engraftment
Isochronic populations of FGRS-ECs (dox-on) were used to perform both single-cell clonal expansion/transplantation and limiting-dilution transplantation (Fig. 3a) . To identify the interval at which FGRS-ECs transition into haematopoietic cells, we used a Runx1 reporter mouse (CD45.2 + Runx1-IRES-GFP) 30 . As RUNX1 is not expressed on endothelial cells, but on fetal haemogenic cells, expression of endogenous Runx1 reports the birth of CD45 − haemogenic-like endothelial cells (Extended Data Fig. 4, Supplementary Video 1) .
On day 8, emerging Runx1-GFP + FGRS-ECs were cloned in individual wells containing fresh VN-ECs and maintained in culture with dox ('FGRS-on'; Fig. 3a, Extended Data Fig. 5a ). On average, 22 ± 11 of 1,000 sorted Runx1-GFP + endothelial cells yielded clonally derived haematopoietic clusters (Fig. 3a, Extended Data Fig. 5a ). We transplanted each haematopoietic cluster into lethally irradiated CD45.1 + recipients and all displayed multi-lineage engraftment from 4 to 16 weeks after transplantation (Fig. 3b, Extended Data Fig. 5b ). We sorted rEC-LKS progeny from clonally derived haematopoietic clusters and quantified the frequency of repopulating cells per clone by limitingdilution transplantation. The frequency of repopulating cells varied in data point (n = 7 independent transplants). c, LDT assay to determine the frequency of LT-HSCs in each expanded rEC-HPSC clone. Averaged CRU per cell determined using Poisson statistics (ELDA software). Boxplot and whiskers represent median, 25th and 75th percentile, mean is represented by + sign (n = 4 independent conversion experiment run in technical triplicates for each conditions); two-tailed unpaired t-test (n = 7 independent LDT analysis). d, LDT showing LT-HSC frequency by day 28, representative of rEC-HSCs. CRU of 1 in 557 was determined using Poisson statistics (ELDA software) (n = 3 independent LDT experiments). article reSearcH different clones, with an average of 16 ± 12 competitive repopulating units (CRU) per 1,000 rEC-LKS cells (average number of LKS: 38,510) (Fig. 3c, Extended Data Fig. 5c ). Viral integration mapping demonstrated that transplanted cells share the same viral integration pattern from the HSC compartment to peripheral-blood-differentiated cells, indicating clonally derived rEC-HSCs have multi-lineage reconstitution capacity (Extended Data Fig. 5d) .
PBS
The other half of purified isochronic Runx1-GFP + FGRS-ECs induced by VN-ECs were expanded in bulk to day 28 and then rEC-LKS cells were sorted by flow cytomery. By turning off FGRS, the CRU frequency within the rEC-LKS cells was quantified by limitingdilution transplantation (Fig. 3a, d ). We found 1.8 CRU per 1,000 rEC-LKS cells (1 in 557; 95% confidence, 1 in 1,004 to 1 in 310), as quantified by Poisson statistics (Fig. 3d) . Considering we had approximately 54,000 phenotypic LKS cells at the time of LDT, our bulk conversion strategy can yield approximately 96 ± 33 repopulating cells. Thus, conditional FGRS expression in adult endothelial cells with angiocrine signals supplied by VN-ECs generates cells clonally capable of selfrenewal and long-term multi-lineage haematopoietic reconstitution, thereby fulfilling the criteria of repopulating rEC-HSCs.
rEC-HSCs/rEC-HSPCs match adult transcriptome
We sorted rEC-LKS cells from day 28 in vitro culture, and from the bone marrow of transplanted secondary recipients, and compared their composite transcriptome to embryonic day 11 (E11) aortagonad-mesonephros endothelium, E11 type-1 pre-HSCs, E11 type-2 pre-HSCs, E12 fetal liver HSCs, E14.5 fetal liver HSCs 31 , and LKS-SLAM cells isolated from WBM secondary transplant recipients. We performed supervised principal component analysis on 96 genes that characterize the transition between fetal to adult HSCs, to define transcriptional distances between different developmental stages. Steady-state wild-type adult HSCs, wild-type fetal cells and pre-HSC cells segregated by deve lopmental stage ( 
rEC-HSC lymphoid progeny confer adaptive immunity
We transplanted week 20, primary-engrafted FGRS-off rEC-HSPCs or WBM controls into immunodeficient Rag1 −/− mice (Fig. 5a ). After 20 weeks, we isolated engrafted CD45.2
+ T cells from peripheral blood and subjected them to polyclonal activation using anti-CD3/CD28 beads and IL-2. Both CD45. 
CD8
+ T cells lysed allogeneic mouse (BALB/c) target cells (Fig. 5b, c) .
We assessed clonal diversity of T cell receptors (TCR) within CD3 +
CD4
+ and CD3 + CD8 + progeny of either WBM or rEC-HSPC donor cells. Normalized RNA-seq read counts (log counts per million reads) mapped to T cell receptor β variable (TCR Vβ) genes were used to estimate the TCR diversity No statistically significant differences between the TCR diversity within T cell progeny of WBM and rEC-HSC-transplanted mice could be identified (Wilcoxon rank-sum test, P = 0.33 and P = 0.2, respectively), as assessed by normalized Shannon index (Fig. 5e) . Hence, transplantation of rEC-HSCs re-establishes a T cell pool as diverse as the WBM control.
We then tested whether secondary Rag1 −/− recipient mice engrafted with rEC-HSPCs were capable of adaptive immune function. Paired analyses of the CDR3 region in the same mice before and after immunization against chicken ovalbumin (OVA) showed enrichment of oligoclonal rearrangements in certain TCR Vβ families following vaccination with OVA (Extended Data Fig. 7f ). T cells with OVA-specific TCRs were quantified using tetramers tracking OVA-specific CD8 + (SIINFEKL/K b tetramers) or OVA-specific CD4 + cells (I-Ab OVA (329-337) tetramers) before and after vaccination (Fig. 5f, g ). Vaccination increased the number of OVA-specific T cells, indicating that rEC-HSPCs can generate T cell subsets with adaptive immune function, an attribute of normal HSCs.
VN-EC angiocrine signals drive conversion
The stepwise conversion detailed here captures molecular snapshots and could deconvolute vascular-niche-derived angiocrine signals that choreograph EHT. Runx1-IRES-GFP mECs ( We isolated and performed CFC analyses on FGRS-ECs (VEcad 
CD45
+ immunophenotype, they no longer required exogenous FGRS to maintain CFC function. Before the specification phase was complete (for example, in VEcad
+ cells), ongoing exogenous FGRS expression was required for CFC activity.
We then used Runx1-IRES-GFP mECs to identify VN-EC angiocrine signals that control rEC-HSPC conversion. Runx1-IRES-GFP FGRS-ECs (dox-on) and VN-EC induction were then challenged with various small molecules modulating putative signalling pathways involved in EHT, including TGFβ , BMP, and CXCL12 (ref. 34). Although none of these agents impaired cell viability, induction was blocked when CXCL12 or BMP signalling was inhibited. Abrogation of activin or TGFβ signalling enhanced the specification phase (Extended Data Fig. 8d-f) .
CXCL12 signals through two receptors, CXCR4 and CXCR7. As CXCR4 is expressed on both mECs and haematopoietic cells, we selectively knocked out Cxcr4 in mECs (Fig. 6a) . Adult lung mECs were isola ted from mice with floxed Cxcr4 alleles (Cxcr4 fl/fl ). These mECs were transduced with FGRS (dox-on) and VN-EC induction. Treatment with Cre-recombinase deleted Cxcr4 and impaired Runx1 induction in mECs (Fig. 6a) . Moreover, activation of CXCR7 safeguarded vascular fate and blocked the EHT process (Extended Data Fig. 8f ). Overexpression of CXCL12 by VN-ECs increased the number of VEcad
+ cells (Extended Data Fig. 8g) . Thus, CXCR4, but not CXCR7, contributed to conversion into rEC-HSPCs. Moreover, Runx1 expression was enhanced by TGFβ inhibition and activation of BMP and CXCL12 signalling. Emergence and expansion of rEC-HSPCs was dependent on CXCL12 signalling (Fig. 6b) , indicating that sequential endothelial cell conversion into rEC-HSPCs provides a tractable approach to screen and identify pathways driving transient EHT. FGRS-driven conversion was not exclusive to lung mECs, we found that mECs isolated from all of the adult organs tested (liver, brain, and kidneys) converted upon transient FGRS expression and VN-EC induction (Extended Data Fig. 9a-d Figs 1a, 2a) . Regardless of whether the endothelial cell preparations had been contaminated, passaging of freshly purified endothelial cells for 30 days (absent of haematopoietic cytokines) leads to loss of contaminating HSPCs. These mEC cultures did not support expansion of FGRS-transduced wild-type long-term (LT)-HSCs (Extended Data  Fig. 1b) . To exclude the possibility that CD45.2 + haematopoietic cells contaminating lung mEC cultures could revert to HSCs upon exogenous FGRS expression, we isolated terminally differentiated CD45.2 + cells from rEC-HSPC-engrafted mice and re-induced FGRS expression for 28 days in co-culture with VN-ECs. After transplant, these cells did not contribute to the host haematopoiesis (Extended Data Fig. 9e ). We also show that our endothelial cell to HSPC conversion follows a TRBV8  TRBV5  TRBV4  TRBV31  TRBV30  TRBV3  TRBV29  TRBV26  TRBV24  TRBV23  TRBV21  TRBV20  TRBV2  TRBV19  TRBV17  TRBV16  TRBV15  TRBV14  TRBV13− article reSearcH hierarchical model (Extended Data Fig. 9f-h) . Thus, the simplest explanation for our findings is that adult endothelial cells were converted to rEC-HSCs and there was no contamination of endothelial cell cultures with host haematopoietic cells.
Discussion
We demonstrate for the first time, to our knowledge, the pluripotencyindependent conversion of adult endothelial cells to functional multipotent cells that meet the criteria of normal HSCs. Transient expression of FGRS reprogramming factors in adult endothelial cells with vascularniche induction readily reprograms these cells to stable, self-renewing HSCs (rEC-HSCs) that are capable of long-term, clonally derived engraftment and haematopoietic reconstitution of myelopoiesis and both innate and adaptive immune function. Adult tissue-specific endothelial cells have a unique plasticity that is missing from other somatic cells, allowing them to undergo efficient transition towards a haematopoietic fate, without the necessity of drifting through a potentially pro-oncogenic pluripotent state. Our approach has translational potential and should also enhance understanding of the evanescent ontological EHT thought to be responsible for all HSCs generated during an individual's lifetime 35 . The pathways that regulate EHT have been difficult to elucidate as only a small number of cells undergo EHT within a short developmental window 36-39 . Here we have developed a stepwise spatially and temporally controlled in vitro model that reveals the signalling pathways driving EHT. We show that direct cellular contact between FGRS-ECs and their vascular niche is essential and sufficient for the birth and self-renewal of rEC-HSCs. The vascular niche supplies key membrane and secreted angiocrine factors, including Notch ligands, c-Kit ligand, BMP2, adhesion molecules, and other unknown factors that drive FGRS-ECs transition into rEC-HSCs 17 . Although BMP and CXCL12-CXCR4 activation accelerated generation of rEC-HSPCs, TGFβ and signalling via the other CXCL12 receptor, CXCR7, blocked haematopoietic induction from endothelial cells. Thus, the vascular-niche platform provides an opportunity to track the cross-talk between emerging rEC-HSCs and the niche cells. Specifically, this vascular-niche platform facilitates the screening of small molecules and identification of transcription factors that enhance specification and self-renewal of HSCs. The clear delineation of niche-dependent induction from specification that we have identified is expected to advance our understanding of the niche-driven developmental processes involved in HSC generation.
Conversion of adult mECs to HSCs appears to be efficient. We showed that a single clone of RUNX1
+ FGRS-EC yield 16 ± 12 CRU per 1,000 phenotypic LKS cells. The variation in the frequency of CRUs that were generated per clone suggests that FGRS stoichiometry affects the quality of the endothelial to HSC conversion. Nonetheless, considering that at minimum a total of 38,510 LKS cells per clone were present at the time of LDT, a single RUNX1 + FGRS-EC can give rise to around 598 ± 463 CRUs (Fig. 3c) . As, by day 8 of conversion, 28.0 ± 4.8% of 250,000 FGRS-ECs express endogenous RUNX1, and 22 ± 11 cells of 1,000 cloned RUNX1 + endothelial cells yield rEC-HSCs (Fig. 6b, Extended Data Fig. 5c ), a total of 1,500 ± 610 rEC-HSCs are generated during reprogramming (1,500 out of 70,000, 2.1%), with an overall conversion efficiency of around 0.6% (1,500 out of 250,000) for the starting population of FGRS-ECs. Theoretically, 24,000 HSCs can be derived from 70,000 RUNX1 + adult mECs during the conversion process.
However, when mECs were converted as bulk culture, we detected a frequency of 1 CRU per 557 phenotypic LKS (Fig. 3d) . Since there were 54,000 phenotypic LKS cells at the time of LDT, the bulk conversion strategy can yield around 97 CRUs. The difference in the number of CRU between the 'bulk' conversion (96 ± 33 CRU per conversion) and the single RUNX1 + FGRS-EC conversion (598 ± 463 CRU) could be explained by complex negative feedback occurring during bulk conversion (Fig. 6b) . Therefore, RUNX1
+ FGRS-EC cultured as bulk or single clones undergo EHT and give rise to expan dable and self-renewing rEC-HSCs capable of long-term engraftment (Fig. 3b, c) .
We did not find haematological or histological evidence of mali gnant transformation for up to 40 weeks in primary (20 weeks) or serial secondary (an additional 20 weeks) recipient mice engrafted with rEC-HSCs (Extended Data Fig. 10 ). RNA-profiling indicates that the signature of rEC-HSPC/rEC-HSCs is similar to adult wild-type HSCs. Indeed, article reSearcH the transcriptome of rEC-HSPC/rEC-HSCs was more closely linked to adult HSCs than to fetal type-1 or type-2 pre-HSCs (Fig. 4) . Therefore, our approach provides a platform for converting readily accessible sources of adult endothelial cells to stable long-term repopulating HSCs.
Although the transcriptome of rEC-HSCs obtained from clonal or bulk conversion were indistinguishable from native adult HSCs, additional experiments will be required to determine whether their endothelial epigenetic landscape is fully erased. Of note, the donor reconstitution observed in our clonal primary transplants often matured after transplantation, with lymphoid or myeloid lineage bias potential correcting over time.
As a large number of adult endothelial cells can be obtained from healthy donors, our approach makes possible future use of autologous endothelial cells to generate long-term HSCs for treatment of acquired and genetic haematological disorders. Because endothelial cells are readily amenable to gene editing, without undergoing cellular attrition, the clonally expanded endothelial cells could generate abundant rEC-HSCs with customized functions, including those yielding adaptive T cell subsets that could treat immunological disorders.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. ) (Roche) at 37 °C for 20-30 min to create a single-cell suspension. Cells were filtered through a 40-µ m filter immediately before counter staining. The single-cell suspension was first blocked with an antibody against CD16/32 (2.4G2) before antibody staining with anti-mouse CD31-PE-Cy7 (390, Biolegend), anti-mouse TER119 (TER119) and anti-mouse CD45 (30-F11). Haematopoietic and erythroid cells were removed via CD45 and TER119 gate exclusion, and adult mouse endothelial cells (mECs) were defined and sorted as VEcad
− cells. Resulting adult mEC cultures were cultured on fibronectin-coated (Sigma-Aldrich) plates in mEC media. Purity of mECs and absence of contaminating haematopoietic cells were confirmed by flow cytometry and confocal microscopy.
Isolation of HUVEC and generation of VN-ECs (HUVEC-E4ORF1).
Human umbilical vein endothelial cells (HUVECs) were isolated as described 29, 40 and cultured in endothelial cell growth medium. Once endothelial cells were transduced with lentiviral vectors expressing E4ORF1 gene they were then cultured in human endothelial cell media (M199 (Sigma, M4530), 10% FBS (Omega Scientific, FB07), 50 µ g ml −1 endothelial mitogen (Alfa Aesar J65416), and 100 µ g ml −1 heparin (Sigma, H3393) 11, 13, 28, 29 . E4ORF1 confers endothelial cells with the capacity to survive in the absence of serum and exogenous growth factors, while sustaining the pre-determined endothelial cell signatures and repertoire of the pro-haematopoietic angiocrine factors. . All niche-dependent experiments described herein were performed by using HUVEC-derived E4ORF1
+ endothelial cells (VN-ECs, HUVEC-E4ORF1, Angiocrine Bioscience) 11,13,19,28,29 as a vascularniche feeder monolayer, except as specifically noted. Virus production and transduction. Open reading frames (Fosb: NM_008036.2, Gfi1: NM_010278.1, Runx1 (Runx1b isoform): NM_001111022.2, Sfpi1: BC003815.1) were cloned into pLVx TET-3G lentiviral plasmid. Lentiviruses (LV) were produced were cloned into doxycycline-inducible pLVx TET-3G lentiviral plasmids. Lentiviral vectors expressing Cxcl12 (NM_001012477.2) were obtained from Cyagen (pLV(Exp)-Neo-EF1A> mCxcl12:IRES:EBFP).
Viral particles were produced in the HEK 293T Lenti-X cell line (Clontech, 632180) using Lenti-X packaging single shot (Clontech, 631275) following the manufacturer's instructions, and titred using Lenti-X p24 Rapid Titer Kit (Clontech, 632200). Transduction was carried out in 6-well plates. Doxycycline (dox) (Sigma-Aldrich) was added at a concentration of 1 µ g ml −1 for FGRS transgene induction. Direct conversion of adult mECs into rEC-HSPCs and rEC-HSCs. Adult mECs were directly converted into haematopoietic cells by conditional enforced expression of transcription factors followed by replating onto a serum-free inductive vascular niche (VN-ECs, HUVEC-E4ORF1). Purified populations of VEcad + CD31 + CD45 − TER119 − mECs were cultured in the mEC growth medium, consisting of DMEM:Ham's F-12 (Sigma, D6421) supplemented with 20% FBS (Omega Scientific, FB07), 20 mM HEPES (Invitrogen, 15630080), 100 µ g ml −1 heparin (Sigma, H3393), 50 µ g ml −1 endothelial mitogen (Alfa Aesar J65416) and 5 µ M SB431542 (R&D, 1614), in a humidified incubator at 37 °C, 5% CO 2 and normoxia 5% O 2 .
Then, adult mECs were transduced with doxycycline-inducible TET-3G lentiviral vectors for a combination of transcription factors and the reverse tetracyclinecontrolled trans-activator-FosB, Gfi1, Runx1, Spi1 (FGRS), and rtTA-and maintained in mEC media for 3 days. FGRS-ECs were then selected for rtTA expression by puromycin resistance. 72 h after puromycin selection, FGRS expression was induced by adding 1 µ g ml −1 dox in mEC media for 48 h. Dox was added every 24 h. FGRS-ECs were then reseeded onto confluent VN-EC monolayers supplemented with conversion media (StemSpan SFEM, STEMCELL Technologies, 09650), 10% KnockOut Serum Replacement (Invitrogen, 10828028), 10 ng ml (C57BL/6J CD45.2 background) mECs were purified to remove contaminating lymphoid endothelial cells and haematopoietic cells. After cultivation for 30 days, pure populations of mECs were then used for direct conversion into HSPCs (rECHSPCs) and HSCs (rEC-HSCs), as described above. Adult lung mECs, devoid of any haematopoietic cells, were primarily used to assess the capacity of the rEC-HSPC and rEC-HSCs to reconstitute primary and secondary, clonal and serial haematopoietic transplantations. On day 28, FGRS-ECs and residual VN-ECs were transplanted at 8.0 × 10 5 cells per recipient into lethally irradiated (950 cGy) congenic recipients. Dox was not administered in the drinking water to ensure no exogenous FGRS expression during the transplant. Serial transplantation from reprogrammed adult lung mECs to HSPCs experiments were performed by transplanting 1.0 × 10 7 unfractionated bone marrow cells into secondary recipients (CD45.1
). Serial transplantation of unfractionated whole bone marrow cells (WBM) from C57BL/6J (CD45.2 + ) were used as controls. In all transplant experiments, peripheral blood and bone marrow analysis was performed at 4-week intervals with antibodies against c-Kit/CD117 (2B8), Sca-1/ Ly-6A (D7), CD48 (HM48-1), and CD150 (mShad150). Lineage antibody cocktail included: CD41 (MWReg30) TER119 (TER119), B220 (RA3-6B2), CD11b (M1/70), Gr1 (RB6-8C5), CD3 (17A2), CD4 (GK1.5), CD8 (YTS156.7.7), CD44 (IM7), CD62l (MEL-14), CD25 (3C7), FoxP3 (150D), TCRγ δ (GL3), CD45.1 (A20), CD45.2 (104), and DAPI to discriminate and eliminate dead cells from analysis. All antibodies were obtained from Biolegend unless mentioned.
For calculation of competitive repopulating units (CRU), recipient mice were transplanted with limiting dilutions of donor-LKS cells (1 to 4,500) together with 500,000 recipient-derived bone marrow cells. Mice were bled every 4 weeks and killed after 16 weeks. Multi-lineage myelo-lymphoid donor-derived contribution in the peripheral blood was assessed using flow cytometry analysis. HSC-CRU frequency and statistical significance was determined using ELDA software (http://bioinf.wehi.edu.au/software/elda/). Immunofluorescence. Samples were permeabilized in PBST and blocked in 5% donkey serum. Samples were incubated for 2 h in primary antibodies blocking solution, washed 3 times in PBS and incubated in secondary antibodies (Jackson Laboratories) for 1 h. Following washing, some sections were counterstained for nucleic acids by DAPI (Invitrogen) before mounting and imaging by confocal microscopy. The primary antibodies used for immunostaining are listed in the article reSearcH previous section. All imaging was performed using a Zeiss 710 META confocal microscope. RNA sequencing, principal component analyses, and hierarchical clustering. At least 100 ng of total RNA from both freshly harvested and cultured cells was isolated (phenol-chloroform separation of TRIzol LS) and purified using Qiagen RNeasy Mini Kit. RNA quality was verified using an Agilent Technologies 2100 Bioanalyzer. RNA library preps were prepared and multiplexed using Illumina TruSeq RNA Library Preparation Kit v2 (non-stranded and poly-A selection) and 10 nM of cDNA was used as input for high-throughput sequencing via Illumina's HiSeq 2500 producing 51 bp paired-end reads. Sequencing reads were demultiplexed (bcl2fastq v2.17), checked for quality (FastQC v0.11.5), and trimmed/ filtered when appropriate (Trimmomatic v0.36). The resultant high-quality reads were mapped (TopHat2 v2.1.0; Bowtie2 v2.2.6) to the transcriptome sequence reference of the UCSC mm10 genome build. Unique and multi-mapped reads were then assembled into transcripts, and abundance measures (FPKM values) quantified (Cufflinks v2.2.1). All subsequent transcriptome data analysis utilized the estimated measurements of transcripts abundance (that is, FPKMs).
Genes with FPKM < 1 were filtered out, and log 2 -transformed FPKM values were used for principal component analysis and hierarchical clustering. Transcriptome-wide and gene-set-specific analysis of the RNA-seq expression dataset were summarized and represented in the forms of scatter plots, dendrograms, and heatmaps. TCR repertoire analyses. TCR repertoire analysis on RNA-seq reads were performed by custom BLAST-mapping. The reads were submitted for nucleotide BLAST-mapping against custom databases comprising TCR Vα genes, Vβ genes, Cα genes, and Cβ genes downloaded from IMGT (http://www.imgt.org). A table of the counts of reads meeting BLAST-expected value cutoffs for each α and β variable and constant gene was formulated for each sample and normalized to counts per million sequenced reads. The Relative Shannon Index was calculated using the Shannon entropy of the counts of TCR Vβ genes normalized by the logarithm of the number of different Vβ genes occurring in each sample and P values showing differences in the Relative Shannon Index were calculated using the Wilcoxon rank-sum test. Heatmaps and clustering were then performed in R using 'heatmap.2' function from gplots package. TCR spectratyping by nested PCR. RNA was isolated from CD45. + male recipients with 500,000 radio-protective CD45.1 + bone marrow haematopoietic cells. CD45.1 + recipient mice were assessed for CD45.2 + engraftment with contaminating HSPCs cells, as described above in section transplantation assays.
(2) To demonstrate that the freshly isolated mEC expansion culture conditions, not supplemented with haematopoietic cytokines, will prevent proliferation or survival of any contaminating haematopoietic cells, limiting dilutions of CD45.2 + wild-type LKS-SLAM cells were introduced into mEC expansion cultures. In these experiments LKS-SLAM cells were transduced with FGRS transgenes to rule out the possibility that these factors will enhance LKS-SLAM cell survival and expansion and seeded in limiting dilution on top of mEC-VN-EC co-culture. As per conversion protocol, these cultures were grown in mEC media (absent haematopoietic cytokines) for 4 weeks. 'Contaminated' mEC-VN-EC co-cultures were then grown in conversion media for 28 days. The resulting cultures were transplanted into three lethally irradiated (950 cGy) CD45.1 + male recipient mice with 500,000 CD45.1 + bone marrow haematopoietic cells to demonstrate that LKS-SLAM cells could not survive such haematopoietic intolerant culture conditions.
(3) Purified mECs were expanded for conversion experiments routinely for 30 days in mEC media in complete absence of haematopoietic cytokines. Then, mECs were transduced with dox-inducible FGRS transgenes but were never exposed to dox (no-dox) and therefore never expressed FGRS transgenes. 8 × 10 5 cultured no-dox FGRS-transgene-transduced 30-day-expanded mECs were transplanted into lethally irradiated (950 cGy) recipient mice in a rescue dose setting to rule out existence of any contaminating haematopoietic cells. ) were cultured for 28 days in conversion media in presence of doxycycline in co-culture with VN-ECs. Resulting cultures were transplanted into three lethally irradiated (950 cGy) CD45.1 + male recipient mice with 500,000 radio-protective bone marrow haematopoietic cells. Then, the recipient CD45.1 + transplanted mice were assessed for CD45.2 + engraftment as described above in the section on transplantation assays.
(5) If host HSPC contamination contributes to rEC-HSPCs and rEC-HSCs, then there should be no hierarchical FGRS-dependence induction, specification or expansion phases during rEC-HSPC generation. In addition, within the first 8 days of culture (induction phase), the contaminating HSPCs should give rise to engraftable HSPCs. To assess this, dox-on FGRS-transduced mECs were passaged through stepwise shutting-off FGRS expression either during the induction, specification or expansion phases. The number of rEC-HSCs and rEC-HSPCs at each stage were then quantified, as described above. and Cxcr4 −/− endothelial cells were transduced with FGRS along with VN-EC induction and converted. Then, the frequency and functionality of the emerging CD45 + rEC-HSPCs and rEC-HSCs were assessed, as described above, by performing phenotypic flow cytometry. Leukaemia assessment. We analysed recipient organ architecture and histological profile after 20 weeks of primary or secondary transplantation for any evidence of malignant alterations. For each organ, including bone marrow, lung, kidney, spleen, liver, intestine and brain, Wright-Giemsa, Masson and PicroSirius Red staining were performed on 10-µ m paraffin-embedded sections (Histoserv). All images were acquired using a colour CCD camera. Primers list. All mouse: Fosb forward 5′ -ACATGCCAGGAACCAGCTAC-3′ ; Fosb reverse, 5′ -GCTGATCAGTTTCCGCCTGA-3′ CCA; Runx1 forward 5′ -GAAGTGTAAGCCCAGCACAGT-3′ ; Runx1 reverse 5′ -GGCGGGGGA TTCTATAATTT-3′ ; Gfi1 forward 5′ -ATGTGCGGCAAGACCTTC-3′ ; Gfi1 reverse 5′ -ACAGTCAAAGCTGCGTTCCT-3′ ; Spi1 forward 5′ -GGAG AAGCTGATGGCTTGG-3′ ; Spi1 reverse 5′ -CAGGCGAATCTTTTTCTTGC-3′ . Viral integration mapping. The primer (Integrated DNA) sets used to detect each sequence were as follows. B1 repeated sequence: 5′ -GTGGTGGCGCA CGCCT-3′ and 5′ -TAGCCCTGGCTGTCCTGGAA-3′ ; LTR: 5′ -TCCACAGATCAA GGATATCTTGTC-3′ . Reactions contained 1× Taqman universal master mix article reSearcH (Perkin-Elmer), 300 nM forward primer, 300 nM reverse primer, 100 nM probe primer and 100− 500 ng of template DNA in a 30-µ l volume. After initial incubations at 50 °C for 2 min and 95 °C for 10 min, 40 cycles of amplification were carried out at 15 s at 95 °C followed by 1 min 30 s at 60 °C. PCR products were then analysed on a 4% TBE-EtBR gel. Statistical analyses. All data are presented as either median ± s.e.m., mean ± s.d., or mean ± s.e.m. (as indicated in figure legends) . The data presented in the figures reflect multiple independent experiments performed on different days using different mice. Unless otherwise mentioned, most of the data presented in figure panels are based on at least three independent experiments. The significance of differences was determined using a two-tailed Student's t-test, unless otherwise stated. P > 0.05 was considered not significant; * P < 0.05; * * P < 0.01; * * * P < 0.001. In all the figures, n refers to the number of mice when applicable. All statistical analyses were performed using Graphpad Prism software. No animals were excluded from analyses. Sample sizes were selected on the basis of previous experiments. Unless otherwise indicated, results are based on three independent experiments to guarantee reproducibility of findings. Data availability. The RNA sequencing dataset was submitted to the Gene Expression Omnibus database with accession number GSE88840. Source Data for this study are included in the online version of the paper. Single-cell RNA-seq datasets for embryonic day 11 (E11) aorta-gonad-mesonephros endothelium, E11 CD201
− pre-HSC type 1, E11 mouse at indicated time points after transplantation. Data represent individual data points, n = 15, four independent reprogramming experiments. f, Schematic representation of haematopoietic recovery following sub-lethal irradiation assay. g, Analysis of white blood cell recovery of rEC-HSPC-engrafted versus control mice following sub-lethal irradiation (500 cGy) (n = 5 for duration of analysis). Data represent mean ± s.e.m., no significant differences were found using two-tailed unpaired t-test. h, Multi-lineage analyses during bone marrow recovery. Myeloid and lymphoid regeneration, including CD3 + CD4 + T cells, and CD3 + CD8 + T cells at baseline and 28 days post sub-lethal irradiation (500 cGy). Data represent individual data points; black bar represents mean (n = 5). 
